◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

IDEXX LABORATORIES INC /DE

CIK: 874716 SIC: 2835
$4.30B
Revenue
$1.06B
Net Income
61.80%
Gross Margin
31.60%
Op. Margin
$1.62B
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 16 annual reports available (2010 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $4.30B $4.30B $3.90B $3.66B $3.37B $3.22B
Revenue Growth % 0.0% 10.4% 6.5% 8.7% 4.7% nan%
Cost of Revenue $1.64B $1.64B $1.52B $1.47B $1.36B $1.33B
+ Gross Profit $2.66B $2.66B $2.38B $2.19B $2.00B $1.89B
Gross Margin % 61.8% 61.8% 61.0% 59.8% 59.5% 58.8%
Operating Expenses $1.30B $1.30B $1.25B $1.09B $1.11B -
Research & Development $251.21M $251.21M $219.79M $190.95M $254.82M $161.01M
+ Operating Income $1.36B $1.36B $1.13B $1.10B $898.76M $932.03M
Operating Margin % 31.6% 31.6% 29.0% 30.0% 26.7% 29.0%
Interest Expense $37.70M $37.70M $33.80M $41.58M $39.86M $29.81M
Income Before Tax $1.32B $1.32B $1.11B $1.06B $859.97M $902.65M
Income Tax Expense $264.73M $264.73M $221.96M $216.13M $180.88M $157.81M
+ Net Income $1.06B $1.06B $887.87M $845.04M $679.09M $744.85M
Net Margin % 24.6% 24.6% 22.8% 23.1% 20.2% 23.2%
Basic EPS nan 13.17 10.77 10.17 8.12 8.74
Diluted EPS nan 13.08 10.67 10.06 8.03 8.60
Basic Shares Outstanding -178K 80.4M 82.5M 83.1M 83.6M 85.2M
Diluted Shares Outstanding -182K 81.0M 83.2M 84.0M 84.6M 86.6M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $180.07M $288.27M $453.93M $112.55M $144.45M
Accounts Receivable $552.38M $473.57M $457.44M $400.62M $368.35M
Inventory $377.76M $381.88M $380.28M $367.82M $269.03M
Other Current Assets $303.62M $256.18M $203.59M $220.49M $173.82M
Total Current Assets $1.41B $1.40B $1.50B $1.10B $955.65M
Property Plant & Equipment $747.38M $713.12M $702.18M $649.47M $587.67M
Goodwill $414.00M $405.10M $365.96M $361.80M $359.35M
Intangible Assets $109.84M $111.68M $84.50M $97.67M $99.03M
Other Non-current Assets $542.48M $547.52M $496.53M $417.73M $330.40M
Total Assets $3.35B $3.29B $3.26B $2.75B $2.44B
Accounts Payable $110.41M $114.21M $110.64M $110.22M $116.14M
Accrued Liabilities $530.15M $502.12M $478.71M $433.66M $458.91M
Deferred Revenue $35.26M $33.80M $37.20M $37.94M $40.03M
Total Current Liabilities $1.15B $1.07B $951.55M $1.24B $763.58M
Long-term Debt $450.00M $449.79M $622.88M $694.39M $775.21M
Deferred Tax Liabilities $31.86M $11.31M $7.24M $8.15M $8.94M
Other Non-current Liabilities $56.53M $44.34M $65.53M $67.59M $70.94M
Total Liabilities $1.75B $1.70B $1.78B $2.14B $1.75B
Common Stock $10.84M $10.78M $10.75M $10.72M $10.69M
Retained Earnings $6.39B $5.33B $4.44B $3.60B $2.92B
Treasury Stock - - - - $3.57B
Total Stockholders Equity $1.61B $1.60B $1.48B $608.74M $689.99M
Total Liabilities & Equity $3.35B $3.29B $3.26B $2.75B $2.44B
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $1.06B $1.06B $887.87M $845.04M $679.09M $744.85M
Depreciation & Amortization $249.08M $145.18M $129.94M $114.91M $111.90M $104.60M
Stock-based Compensation $104.10M $60.01M $60.30M $59.74M $49.77M $37.76M
Deferred Income Tax - $131.20M $-24.19M $-48.31M - -
Change in Receivables $188.85M $68.72M $28.28M $53.87M $41.40M $33.14M
Change in Inventory $2.71M $789.00K $28.00M $28.65M $121.73M $52.92M
Change in Payables $-28.81M $-8.57M $8.09M $-557.00K $3.47M -
Operating Cash Flow $1.84B $1.18B $929.00M $906.51M $542.98M $755.55M
Capital Expenditure $218.83M $124.68M $120.92M $133.63M $148.84M $119.55M
Acquisitions - - $76.69M - $11.51M $173.42M
Investing Cash Flow $-229.09M $-136.24M $-207.06M $-125.25M $-195.35M $-292.97M
Stock Repurchased $2.36B $1.22B $837.03M $71.92M $819.71M $746.78M
Financing Cash Flow $-1.99B $-1.16B $-878.07M $-442.00M $-370.94M $-697.41M
Net Change in Cash $-356.16M $-108.20M $-165.67M $341.39M $-31.91M $-239.47M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $1.11B - $3.21B -
Cost of Revenue $421.88M - $1.21B -
Gross Profit $683.35M - $2.00B -
Operating Expenses $328.51M - $957.04M -
Research & Development $63.41M - $184.37M -
Operating Income $354.85M - $1.04B -
Interest Expense $10.65M - $29.64M -
Income Before Tax $344.77M - $1.02B -
Income Tax Expense $70.16M - $205.93M -
Net Income $274.61M $203.30M $811.28M -
Basic EPS 3.43 - 10.06 -
Diluted EPS 3.40 - 9.99 -
Basic Shares Outstanding $80.10M - $80.61M -
Diluted Shares Outstanding $80.67M - $81.21M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $208.17M $288.27M
Accounts Receivable $566.88M $473.57M
Inventory $391.56M $381.88M
Other Current Assets $310.44M $256.18M
Total Current Assets $1.48B $1.40B
Property Plant & Equipment $739.44M $713.12M
Goodwill $413.65M $405.10M
Intangible Assets $114.79M $111.68M
Other Non-current Assets $513.57M $547.52M
Total Assets $3.39B $3.29B
Accounts Payable $122.27M $114.21M
Accrued Liabilities $488.86M $502.12M
Deferred Revenue $35.69M $33.80M
Total Current Liabilities $1.25B $1.07B
Long-term Debt $374.82M $449.79M
Deferred Tax Liabilities $3.72M $11.31M
Other Non-current Liabilities $57.62M $44.34M
Total Liabilities $1.83B $1.70B
Common Stock $10.83M $10.78M
Retained Earnings $6.14B $5.33B
Total Stockholders Equity $1.56B $1.60B
Total Liabilities & Equity $3.39B $3.29B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $274.61M $203.30M $811.28M -
Depreciation & Amortization - - $106.46M -
Stock-based Compensation - - $43.90M -
Change in Receivables - - $82.59M -
Change in Inventory - - $2.20M -
Change in Payables - - $-4.98M -
Operating Cash Flow - - $826.04M -
Capital Expenditure - - $95.24M -
Acquisitions - - - -
Investing Cash Flow - - $-108.11M -
Stock Repurchased - - $979.19M -
Financing Cash Flow - - $-809.26M -
Net Change in Cash - - $-80.10M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...